<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK338165" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK338165/" /><meta name="ncbi_pagename" content="Autosomal Dominant Leukodystrophy with Autonomic Disease - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Autosomal Dominant Leukodystrophy with Autonomic Disease - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Autosomal Dominant Leukodystrophy with Autonomic Disease" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2016/01/07" /><meta name="citation_author" content="Norah Nahhas" /><meta name="citation_author" content="Parisa Sabet Rasekh" /><meta name="citation_author" content="Adeline Vanderver" /><meta name="citation_author" content="Quasar Padiath" /><meta name="citation_pmid" content="26749591" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK338165/" /><meta name="citation_keywords" content="ADLD" /><meta name="citation_keywords" content="Adult-Onset Autosomal Dominant Leukodystrophy with Autonomic Symptoms" /><meta name="citation_keywords" content="Autosomal Dominant Adult-Onset Demyelinating Leukodystrophy" /><meta name="citation_keywords" content="LMNB1-Related Adult-Onset Autosomal Dominant Leukodystrophy" /><meta name="citation_keywords" content="Adult-Onset Autosomal Dominant Leukodystrophy with Autonomic Symptoms" /><meta name="citation_keywords" content="Autosomal Dominant Adult-Onset Demyelinating Leukodystrophy" /><meta name="citation_keywords" content="LMNB1-Related Adult-Onset Autosomal Dominant Leukodystrophy" /><meta name="citation_keywords" content="ADLD" /><meta name="citation_keywords" content="Lamin-B1" /><meta name="citation_keywords" content="LMNB1" /><meta name="citation_keywords" content="Autosomal Dominant Leukodystrophy with Autonomic Disease" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Autosomal Dominant Leukodystrophy with Autonomic Disease" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Norah Nahhas" /><meta name="DC.Contributor" content="Parisa Sabet Rasekh" /><meta name="DC.Contributor" content="Adeline Vanderver" /><meta name="DC.Contributor" content="Quasar Padiath" /><meta name="DC.Date" content="2016/01/07" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK338165/" /><meta name="description" content="Autosomal dominant leukodystrophy with autonomic disease (ADLD) is a slowly progressive disorder of central nervous system white matter characterized by onset of autonomic dysfunction in the fourth to fifth decade, followed in months to years by pyramidal and cerebellar involvement. Autonomic dysfunction can include bladder dysfunction, constipation, postural hypotension, feeding difficulties, erectile dysfunction, and (less often) impaired sweating. Pyramidal signs are often more prominent in the lower extremities (i.e., spastic weakness, hypertonia, clonus, brisk deep tendon reflexes, and bilateral Babinski signs). Cerebellar signs typically appear at the same time as the pyramidal signs and can include gait ataxia, dysdiadochokinesia, intention tremor, dysmetria, and nystagmus. Although cognitive function is usually preserved or only mildly impaired early in the disease course, dementia and psychiatric manifestations can occur as late manifestations. Affected individuals may survive for decades after onset." /><meta name="og:title" content="Autosomal Dominant Leukodystrophy with Autonomic Disease" /><meta name="og:type" content="book" /><meta name="og:description" content="Autosomal dominant leukodystrophy with autonomic disease (ADLD) is a slowly progressive disorder of central nervous system white matter characterized by onset of autonomic dysfunction in the fourth to fifth decade, followed in months to years by pyramidal and cerebellar involvement. Autonomic dysfunction can include bladder dysfunction, constipation, postural hypotension, feeding difficulties, erectile dysfunction, and (less often) impaired sweating. Pyramidal signs are often more prominent in the lower extremities (i.e., spastic weakness, hypertonia, clonus, brisk deep tendon reflexes, and bilateral Babinski signs). Cerebellar signs typically appear at the same time as the pyramidal signs and can include gait ataxia, dysdiadochokinesia, intention tremor, dysmetria, and nystagmus. Although cognitive function is usually preserved or only mildly impaired early in the disease course, dementia and psychiatric manifestations can occur as late manifestations. Affected individuals may survive for decades after onset." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK338165/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/lad-ad/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK338165/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8DC5A9E0406F0100000000054301F0.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK338165_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK338165_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/higes/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/adnfle/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK338165_"><span class="title" itemprop="name">Autosomal Dominant Leukodystrophy with Autonomic Disease</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonyms: ADLD, Adult-Onset Autosomal Dominant Leukodystrophy with Autonomic Symptoms, Autosomal Dominant Adult-Onset Demyelinating Leukodystrophy, <i>LMNB1</i>-Related Adult-Onset Autosomal Dominant Leukodystrophy</div><p class="contrib-group"><span itemprop="author">Norah Nahhas</span>, MD, <span itemprop="author">Parisa Sabet Rasekh</span>, MD, <span itemprop="author">Adeline Vanderver</span>, MD, and <span itemprop="author">Quasar Padiath</span>, MBBS, PhD.</p><a data-jig="ncbitoggler" href="#__NBK338165_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK338165_ai__"><div class="contrib half_rhythm"><span itemprop="author">Norah Nahhas</span>, MD<div class="affiliation small">Children's National Health System<br />Washington, DC<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.lanoitansnerdlihc@sahhann" class="oemail">gro.lanoitansnerdlihc@sahhann</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Parisa Sabet Rasekh</span>, MD<div class="affiliation small">Children's National Health System<br />Washington, DC<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.lanoitansnerdlihc@artebasp" class="oemail">gro.lanoitansnerdlihc@artebasp</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Adeline Vanderver</span>, MD<div class="affiliation small">Children's Hospital of Philadelphia<br />Philadelphia, Pennsylvania<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.pohc.liame@arevrednav" class="oemail">ude.pohc.liame@arevrednav</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Quasar Padiath</span>, MBBS, PhD<div class="affiliation small">University of Pittsburgh<br />Pittsburgh, Pennsylvania<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.ttip@htaidapq" class="oemail">ude.ttip@htaidapq</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">January 7, 2016</span>.</p><p><em>Estimated reading time: 21 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="lad-ad.Summary" itemprop="description"><h2 id="_lad-ad_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Autosomal dominant leukodystrophy with autonomic disease (ADLD) is a slowly progressive disorder of central nervous system white matter characterized by onset of autonomic dysfunction in the fourth to fifth decade, followed in months to years by pyramidal and cerebellar involvement. Autonomic dysfunction can include bladder dysfunction, constipation, postural hypotension, feeding difficulties, erectile dysfunction, and (less often) impaired sweating. Pyramidal signs are often more prominent in the lower extremities (i.e., spastic weakness, hypertonia, clonus, brisk deep tendon reflexes, and bilateral Babinski signs). Cerebellar signs typically appear at the same time as the pyramidal signs and can include gait ataxia, dysdiadochokinesia, intention tremor, dysmetria, and nystagmus. Although cognitive function is usually preserved or only mildly impaired early in the disease course, dementia and psychiatric manifestations can occur as late manifestations. Affected individuals may survive for decades after onset.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of ADLD is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with suggestive clinical and MRI findings and either an <i>LMNB1</i> <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> or (more rarely) a large <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> upstream of the <i>LMNB1</i> promoter.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Treatment is symptomatic. Autonomic dysfunction:</p><ul><li class="half_rhythm"><div>Neurogenic bladder may require management of urinary retention and/or urgency and recurrent urinary tract infection.</div></li><li class="half_rhythm"><div>Constipation may require good hydration, increased dietary fiber, stool softeners, and/or laxatives.</div></li><li class="half_rhythm"><div>Hypotensive events can be minimized by pharmacologic intervention, physical therapy, and increased dietary salt.</div></li><li class="half_rhythm"><div>Feeding difficulties can be managed with speech therapy and appropriate feeding interventions to assure adequate nutrition while preventing aspiration pneumonia.</div></li></ul><p>Spasticity may be treated with medications and physical therapy. Ataxia can be managed with strategies to minimize falls and increase strength, and adaptive equipment such as walkers or wheelchairs.</p><p><i>Surveillance:</i> Routine assessment of: weight, nutrition, and feeding; pulmonary status (re possible recurrent pneumonia); bladder and erectile function; psychosocial well-being; and medications and their doses to avoid iatrogenic polypharmacy. At least yearly assessment: by a neurologist for disease manifestations and progression; and by a physiatrist, orthopedist, physical therapist, and occupational therapist to address orthopedic, equipment, and functional needs.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>ADLD is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. To date all individuals with ADLD have inherited a large <i>LMNB1</i> <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> (or large <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> upstream of <i>LMNB)</i> from an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent. Each child of an individual with ADLD has a 50% chance of inheriting the ADLD-related <i>LMNB1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. When the ADLD-related <i>LMNB1</i> pathogenic variant has been identified in an affected family member, prenatal testing for pregnancies at increased risk is possible.</p></div></div><div id="lad-ad.Diagnosis"><h2 id="_lad-ad_Diagnosis_">Diagnosis</h2><p>No formal diagnostic criteria exist.</p><div id="lad-ad.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Autosomal dominant leukodystrophy with autonomic disease (ADLD) <b>should be suspected</b> in adults with the following clinical and neuroimaging features:</p><p><b>Clinical features</b></p><ul><li class="half_rhythm"><div>Onset in the fourth to fifth decade of signs and symptoms of autonomic dysfunction including bladder dysfunction, constipation, erectile dysfunction, and postural hypotension</div></li><li class="half_rhythm"><div>Subsequent onset of motor and cerebellar impairment resulting in spasticity, ataxia, and tremor</div></li></ul><p><b>MRI findings.</b> Specific brain and spine MRI findings that suggest the diagnosis of ADLD [<a class="bk_pop" href="#lad-ad.REF.bergui.1997.423">Bergui et al 1997</a>, <a class="bk_pop" href="#lad-ad.REF.melberg.2006.904">Melberg et al 2006</a>, <a class="bk_pop" href="#lad-ad.REF.sundblom.2009.328">Sundblom et al 2009</a>] include the following:</p><ul><li class="half_rhythm"><div class="half_rhythm">The cerebral white matter demonstrates symmetric T<sub>2</sub>-weighted hyperintensities extending from the motor cortex, following corticospinal tracts downward through the posterior limb of the internal capsule toward the medulla oblongata. Over time the signal abnormalities extend from the frontoparietal lobe to the occipital lobe and finally the temporal lobe to become completely confluent (<a class="figpopup" href="/books/NBK338165/figure/lad-ad.F1/?report=objectonly" target="object" rid-figpopup="figladadF1" rid-ob="figobladadF1">Figure 1C</a>, thick arrow).</div></li><li class="half_rhythm"><div class="half_rhythm">U-fibers and optic radiations are usually spared.</div></li><li class="half_rhythm"><div class="half_rhythm">The periventricular white matter is usually spared or mildly <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>.</div></li><li class="half_rhythm"><div class="half_rhythm">The upper and middle cerebellar peduncles are almost always involved with marked T<sub>2</sub>-weighted hyperintensity; however, in rare instances they can be spared [<a class="bk_pop" href="#lad-ad.REF.bergui.1997.423">Bergui et al 1997</a>] (<a class="figpopup" href="/books/NBK338165/figure/lad-ad.F1/?report=objectonly" target="object" rid-figpopup="figladadF1" rid-ob="figobladadF1">Figure 1A</a>, thin arrow).</div></li><li class="half_rhythm"><div class="half_rhythm">Brain stem atrophy is present with increased signal intensity of the medulla oblongata. There is diffuse thinning and atrophy of the spinal cord, often with diffuse homogeneous T<sub>2</sub>-weighted hyperintensity.</div></li><li class="half_rhythm"><div class="half_rhythm">Atrophy of the cerebrum, cerebellum, and corpus callosum may develop over time.</div></li><li class="half_rhythm"><div class="half_rhythm">No pathologic enhancement is seen after contrast administration.</div><div class="half_rhythm">Note: The brain and spinal cord MRI findings can precede clinical manifestations by decades.</div></li></ul><div class="iconblock whole_rhythm clearfix ten_col fig" id="figladadF1" co-legend-rid="figlgndladadF1"><a href="/books/NBK338165/figure/lad-ad.F1/?report=objectonly" target="object" title="Figure 1. " class="img_link icnblk_img figpopup" rid-figpopup="figladadF1" rid-ob="figobladadF1"><img class="small-thumb" src="/books/NBK338165/bin/lad-ad-Image001.gif" src-large="/books/NBK338165/bin/lad-ad-Image001.jpg" alt="Figure 1. . T2-weighted MRI from a male age 55 years with ADLD with sections through the brain stem (A), internal capsule (B), and parietal regions (C)." /></a><div class="icnblk_cntnt" id="figlgndladadF1"><h4 id="lad-ad.F1"><a href="/books/NBK338165/figure/lad-ad.F1/?report=objectonly" target="object" rid-ob="figobladadF1">Figure 1. </a></h4><p class="float-caption no_bottom_margin">T<sub>2</sub>-weighted MRI from a male age 55 years with ADLD with sections through the brain stem (A), internal capsule (B), and parietal regions (C). Characteristic involvement of the middle cerebellar peduncles and brain stem features (A, thin arrow), and confluent <a href="/books/NBK338165/figure/lad-ad.F1/?report=objectonly" target="object" rid-ob="figobladadF1">(more...)</a></p></div></div></div><div id="lad-ad.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of ADLD <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with suggestive clinical and MRI findings and either an <i>LMNB1</i> <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> or (more rarely) a large <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> upstream of the <i>LMNB1</i> promoter [<a class="bk_pop" href="#lad-ad.REF.giorgio.2015.3143">Giorgio et al 2015</a>] (see <a href="#lad-ad.Molecular_Genetics">Molecular Genetics</a> and <a class="figpopup" href="/books/NBK338165/table/lad-ad.T.molecular_genetic_testing_used/?report=objectonly" target="object" rid-figpopup="figladadTmoleculargenetictestingused" rid-ob="figobladadTmoleculargenetictestingused">Table 1</a>).</p><p>Molecular genetic testing approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b>, use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>, and <b>more comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b>.</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a>/<a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> analysis of <i>LMNB1</i> should be performed in individuals with classic clinical and neuroimaging features of ADLD.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>LMNB1</i> and other genes of interest (see <a href="#lad-ad.Differential_Diagnosis">Differential Diagnosis</a>) may also be considered.</div><div class="half_rhythm">Note: (1) Attention should be given to whether the panel includes <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a>/<a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> analysis, as sequence variants of <i>LMNB1</i> are not known to be associated with ADLD. (2) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (3) Some multigene panels may include genes not associated with the condition discussed in this GeneReview; thus, clinicians need to determine which <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</div><div class="half_rhythm">For an intoduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a></div></li><li class="half_rhythm"><div class="half_rhythm"><b>More comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (when available) including <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>, mitochondrial sequencing, and <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a> may be considered if serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing (and/or use of a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> that includes <i>LMNB1</i>) fails to confirm a diagnosis in an individual with features of ADLD. Such testing may provide or suggest a diagnosis not previously considered (e.g., mutation of a different gene that results in a similar clinical presentation). For an introduction to comprehensive genomic testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</div></li></ul><div id="lad-ad.T.molecular_genetic_testing_used" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Autosomal Dominant Leukodystrophy with Autonomic Disease (ADLD)</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK338165/table/lad-ad.T.molecular_genetic_testing_used/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__lad-ad.T.molecular_genetic_testing_used_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_lad-ad.T.molecular_genetic_testing_used_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_lad-ad.T.molecular_genetic_testing_used_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_lad-ad.T.molecular_genetic_testing_used_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by This Method</th></tr></thead><tbody><tr><td headers="hd_h_lad-ad.T.molecular_genetic_testing_used_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>LMNB1</i></td><td headers="hd_h_lad-ad.T.molecular_genetic_testing_used_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>3,&#x000a0;4</sup></td><td headers="hd_h_lad-ad.T.molecular_genetic_testing_used_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div><i>LMNB1</i> <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> in 23/24 published families&#x000a0;<sup>5</sup></div></li><li class="half_rhythm"><div>A large <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> upstream of the <i>LMNB1</i> promoter in 1/24 published families&#x000a0;<sup>6</sup></div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="lad-ad.TF.1.1"><p class="no_margin">See <a href="/books/NBK338165/#lad-ad.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="lad-ad.TF.1.2"><p class="no_margin">See <a href="#lad-ad.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="lad-ad.TF.1.3"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>4. </dt><dd><div id="lad-ad.TF.1.4"><p class="no_margin">To include analysis upstream of the <i>LMNB1</i> promoter (see <a href="#lad-ad.Molecular_Genetics">Molecular Genetics</a>)</p></div></dd><dt>5. </dt><dd><div id="lad-ad.TF.1.5"><p class="no_margin"><a class="bk_pop" href="#lad-ad.REF.padiath.2006.1114">Padiath et al [2006]</a>, <a class="bk_pop" href="#lad-ad.REF.giorgio.2013.1160">Giorgio et al [2013]</a>, <a class="bk_pop" href="#lad-ad.REF.potic.2013.2124">Potic et al [2013]</a></p></div></dd><dt>6. </dt><dd><div id="lad-ad.TF.1.6"><p class="no_margin"><a class="bk_pop" href="#lad-ad.REF.giorgio.2015.3143">Giorgio et al [2015]</a></p></div></dd></dl></div></div></div></div></div><div id="lad-ad.Clinical_Characteristics"><h2 id="_lad-ad_Clinical_Characteristics_">Clinical Characteristics</h2><div id="lad-ad.Clinical_Description"><h3>Clinical Description</h3><p>Autosomal dominant leukodystrophy with autonomic disease (ADLD) is a slowly progressive neurologic disorder of central nervous system white matter. Adults show autonomic dysfunction, the first evidence of the disorder, in the fourth to fifth decade of life, followed by pyramidal and cerebellar abnormalities resulting in spasticity, ataxia, and tremor [<a class="bk_pop" href="#lad-ad.REF.finnsson.2015.412">Finnsson et al 2015</a>].</p><p>Specific clinical features, as described in more than 70 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals with a molecularly confirmed diagnosis, include the following:</p><p><b>Autonomic dysfunction,</b> a nearly constant feature [<a class="bk_pop" href="#lad-ad.REF.padiath.2010.337">Padiath &#x00026; Fu 2010</a>], includes bladder dysfunction, constipation, postural hypotension, erectile dysfunction, and less often impaired sweating. Symptoms of autonomic dysfunction may be the initial disease presentation and can precede the motor and cerebellar manifestations by months to years.</p><ul><li class="half_rhythm"><div>Neurogenic bladder is commonly complicated by urinary urgency and/or incomplete bladder emptying, which is often complicated by urinary tract infection.</div></li><li class="half_rhythm"><div>Orthostatic hypotension can be asymptomatic or symptomatic (frequent fainting results in significant functional disability) [<a class="bk_pop" href="#lad-ad.REF.finnsson.2015.412">Finnsson et al 2015</a>].</div></li><li class="half_rhythm"><div>Although less commonly reported, anhidrosis can lead to body temperature dysregulation (mainly hypothermia), which can be severe and even fatal. Infection may exacerbate temperature instability; for example, body temperature decreased to 29.5&#x000b0; C in one individual with a urinary tract infection [<a class="bk_pop" href="#lad-ad.REF.meijer.2008.1496">Meijer et al 2008</a>, <a class="bk_pop" href="#lad-ad.REF.finnsson.2015.412">Finnsson et al 2015</a>].</div></li><li class="half_rhythm"><div>It has been hypothesized that spinal cord white matter involvement [<a class="bk_pop" href="#lad-ad.REF.finnsson.2015.412">Finnsson et al 2015</a>] and <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> noradrenergic failure [<a class="bk_pop" href="#lad-ad.REF.guaraldi.2011.123">Guaraldi et al 2011</a>] result in the autonomic dysfunction seen in this disorder.</div></li></ul><p><b>Pyramidal signs and symptoms</b> usually develop after manifestations of autonomic dysfunction; however, gait difficulties have been reported as the first manifestations [<a class="bk_pop" href="#lad-ad.REF.finnsson.2015.412">Finnsson et al 2015</a>]. Pyramidal manifestations include signs of upper motor neuron dysfunction, often more prominent in the lower extremities (e.g., spastic weakness, hypertonia, clonus, brisk deep tendon reflexes, and bilateral Babinski signs). Spasticity can cause muscle pain and joint contractures. Over time, pyramidal dysfunction extends to the upper extremities.</p><p><b>Cerebellar signs</b> that typically appear at the same time as the pyramidal signs include gait ataxia, dysdiadochokinesia, intention tremor, dysmetria, and nystagmus. Upper extremity postural tremor accompanied by neck tremor (resulting in head titubation) or jaw tremor (affecting speech and chewing) can also be seen [<a class="bk_pop" href="#lad-ad.REF.schwankhaus.1988.1004">Schwankhaus et al 1988</a>].</p><p><b>Cognitive function</b> is usually preserved or mildly impaired early in the disease course; however, dementia and psychiatric manifestations can occur as late manifestations [<a class="bk_pop" href="#lad-ad.REF.dos_santos.2012.579">Dos Santos et al 2012</a>, <a class="bk_pop" href="#lad-ad.REF.finnsson.2015.412">Finnsson et al 2015</a>].</p><p><b>Additional features</b> include:</p><ul><li class="half_rhythm"><div>Pseudobulbar palsy with dysarthria, dysphagia, and forced crying and laughing [<a class="bk_pop" href="#lad-ad.REF.quattrocolo.1997.53">Quattrocolo et al 1997</a>], which can affect feeding and lead to aspiration pneumonia and/or malnutrition;</div></li><li class="half_rhythm"><div>Loss of position and vibration sensation attributed to extensive involvement of the spinal cord;</div></li><li class="half_rhythm"><div>In rare cases, sensorineural hearing loss [<a class="bk_pop" href="#lad-ad.REF.schwankhaus.1994.757">Schwankhaus et al 1994</a>].</div></li></ul><p>Affected individuals may survive for decades after onset of symptoms. Motor manifestations are usually slowly progressive without acute exacerbations; however, some <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals report reversible worsening of cognitive function and gait with fever [<a class="bk_pop" href="#lad-ad.REF.finnsson.2015.412">Finnsson et al 2015</a>].</p><p><b>Neurophysiologic studies</b> are largely non-contributory.</p><ul><li class="half_rhythm"><div>Electromyograms (EMG), visual evoked potentials (VEP), and nerve conduction studies (NCS) are normal [<a class="bk_pop" href="#lad-ad.REF.padiath.2010.337">Padiath &#x00026; Fu 2010</a>].</div></li><li class="half_rhythm"><div>Brain stem auditory evoked potential (BAEP) and somatosensory evoked potentials (SEP) demonstrate nonspecific conductive delays [<a class="bk_pop" href="#lad-ad.REF.schwankhaus.1994.757">Schwankhaus et al 1994</a>].</div></li><li class="half_rhythm"><div>Electroencephalograms (EEG) are normal or show diffuse slowing of electrical activity with no epileptic discharges [<a class="bk_pop" href="#lad-ad.REF.schwankhaus.1994.757">Schwankhaus et al 1994</a>].</div></li></ul><p><b>Laboratory findings</b></p><ul><li class="half_rhythm"><div>CSF analysis is usually normal with no oligoclonal bands; rarely, however, slight increases in protein and Immunoglobulin levels are observed [<a class="bk_pop" href="#lad-ad.REF.schwankhaus.1994.757">Schwankhaus et al 1994</a>].</div></li><li class="half_rhythm"><div>Orthostatic hypotension has prompted measurements of catecholamines. Blood norepinephrine levels are in the low normal range and drop further when individuals with ADLD stand. In 24-hour urine samples excretion of epinephrine was low [<a class="bk_pop" href="#lad-ad.REF.eldridge.1984.948">Eldridge et al 1984</a>].</div></li><li class="half_rhythm"><div>Peripheral nerve biopsy is normal.</div></li></ul></div><div id="lad-ad.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>Genotype-<a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> correlations are not observed.</p></div><div id="lad-ad.Penetrance"><h3>Penetrance</h3><p>The disease presents in the fourth to fifth decades of adulthood with no gender variation. Penetrance is not known but is thought to be 100%.</p></div><div id="lad-ad.Nomenclature"><h3>Nomenclature</h3><p>ADLD was originally referred to as "<a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> leukodystrophy mimicking chronic progressive multiple sclerosis" or "adult-onset leukodystrophy simulating chronic progressive multiple sclerosis" [<a class="bk_pop" href="#lad-ad.REF.eldridge.1984.948">Eldridge et al 1984</a>, <a class="bk_pop" href="#lad-ad.REF.schwankhaus.1994.757">Schwankhaus et al 1994</a>].</p></div><div id="lad-ad.Prevalence"><h3>Prevalence</h3><p>The exact prevalence of <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> leukodystrophy with autonomic disease (ADLD) is unknown. Published cases include 24 families with more than 70 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals; it is likely that many more unpublished families have now been identified.</p><p>Families of different origins have been reported:</p><ul><li class="half_rhythm"><div>Irish-American [<a class="bk_pop" href="#lad-ad.REF.eldridge.1984.948">Eldridge et al 1984</a>]</div></li><li class="half_rhythm"><div>Italian [<a class="bk_pop" href="#lad-ad.REF.quattrocolo.1997.53">Quattrocolo et al 1997</a>, <a class="bk_pop" href="#lad-ad.REF.brussino.2009.237">Brussino et al 2009</a>]</div></li><li class="half_rhythm"><div>Swedish [<a class="bk_pop" href="#lad-ad.REF.marklund.2006.608">Marklund et al 2006</a>]</div></li><li class="half_rhythm"><div>French-Canadian [<a class="bk_pop" href="#lad-ad.REF.meijer.2008.1496">Meijer et al 2008</a>]</div></li><li class="half_rhythm"><div>German [<a class="bk_pop" href="#lad-ad.REF.dos_santos.2012.579">Dos Santos et al 2012</a>]</div></li><li class="half_rhythm"><div>Israeli [<a class="bk_pop" href="#lad-ad.REF.schuster.2011.65">Schuster et al 2011</a>]</div></li><li class="half_rhythm"><div>Serbian [<a class="bk_pop" href="#lad-ad.REF.potic.2013.2124">Potic et al 2013</a>]</div></li><li class="half_rhythm"><div>Japanese [<a class="bk_pop" href="#lad-ad.REF.padiath.2006.1114">Padiath et al 2006</a>]</div></li></ul></div></div><div id="lad-ad.Genetically_Related_Allelic_Disor"><h2 id="_lad-ad_Genetically_Related_Allelic_Disor_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with pathogenic variants in <i>LMNB1</i>.</p></div><div id="lad-ad.Differential_Diagnosis"><h2 id="_lad-ad_Differential_Diagnosis_">Differential Diagnosis</h2><p>See <a href="/books/n/gene/leukodys-ov/">Leukodystrophy Overview</a>.</p><p>The differential diagnosis of <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> leukodystrophy with autonomic disease (ADLD) includes other leukodystrophies with adult onset as well as acquired demyelinating disorders such as multiple sclerosis.</p><p><b>Multiple sclerosis (MS)</b> is an inflammatory disease that affects central nervous system white matter. The age of presentation, combination of motor, cerebellar, and autonomic manifestations make this disorder in some instances similar to ADLD [<a class="bk_pop" href="#lad-ad.REF.eldridge.1984.948">Eldridge et al 1984</a>]. Unlike the brain MRI in ADLD, the brain MRI in MS is characterized by multifocal lesions mainly around the periventricular area, brain stem, cerebellum, and spinal cord [<a class="bk_pop" href="#lad-ad.REF.noseworthy.2000.938">Noseworthy et al 2000</a>]. CSF contains high IgG and oligoclonal bands [<a class="bk_pop" href="#lad-ad.REF.poser.1983.227">Poser et al 1983</a>]. Available data suggest that multiple sclerosis is inherited as a complex <a class="def" href="/books/n/gene/glossary/def-item/multifactorial/">multifactorial</a> disorder that results from the interaction of genetic and environmental factors.</p><p><b>Vitamin B<sub>12</sub> deficiency.</b> While the first manifestation of vitamin B<sub>12</sub> deficiency is typically megaloblastic anemia, on occasion the first manifestations can be the neurologic findings of subacute combined degeneration involving the spinal cord (myelopathy, loss of position and vibration sensation, bladder incontinence, and gait ataxia), peripheral nerves, and brain (neuropsychiatric disturbance). These neurologic findings can be confused with those of ADLD. In vitamin B<sub>12</sub> deficiency, MRI changes include hyperintense T<sub>2</sub>-weighted changes in the spinal cord.</p><p>Because untreated vitamin B<sub>12</sub> deficiency is associated with progressive neurologic deterioration and because early detection and treatment can improve the long-term outcome, it is important that vitamin B<sub>12</sub> deficiency be considered in the differential diagnosis of ADLD [<a class="bk_pop" href="#lad-ad.REF.rabhi.2011.166">Rabhi et al 2011</a>, <a class="bk_pop" href="#lad-ad.REF.devalia.2014.496">Devalia et al 2014</a>, <a class="bk_pop" href="#lad-ad.REF.issac.2015.26">Issac et al 2015</a>].</p><p><b>Spinocerebellar ataxias types 2 and 3 (</b><a href="/books/n/gene/sca2/"><b>SCA2</b></a>
<b>and</b>
<a href="/books/n/gene/sca3/"><b>SCA3</b></a><b>)</b> are slowly progressive, adult-onset, <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> ataxias caused by CAG <a class="def" href="/books/n/gene/glossary/def-item/trinucleotide-repeat/">trinucleotide repeat</a> expansions in <i>ATXN2</i> and <i>ATXN3,</i> respectively. Manifestations of SCA2 and SCA3 that overlap with those of ADLD include cerebellar gait ataxia, autonomic disturbances, pyramidal involvement, and dysarthria; manifestations that do not overlap with ADLD include nystagmus, peripheral neuropathy, abnormal movements, and seizures. Unlike ADLD, no specific radiologic changes are observed in the SCAs. See also <a href="/books/n/gene/ataxias/">Hereditary Ataxia Overview</a>.</p><p><a href="/books/n/gene/alexander/"><b>Alexander disease</b></a> is an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> leukodystrophy that predominantly affects infants and children and is caused by mutation of <i>GFAP</i>. The adult form of Alexander disease (accounting for ~33% of cases) is associated with range of clinical manifestations that overlap with ADLD: bulbar/pseudobulbar signs, pyramidal signs, cerebellar signs, gait disturbance, sleep disturbance, and dysautonomia. Brain MRI in Alexander disease usually shows white matter signal changes in the frontal lobe, periventricular area, basal ganglia, thalami, and brain stem with contrast enhancement, changes that are quite different from those of ADLD.</p><p><a href="/books/n/gene/hdls/"><b>Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia</b></a>
<b>(ALSP)</b> is an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> adult-onset leukodystrophy caused by mutation of <i>CSF1R</i>. Frontal lobe syndrome and personality changes (which are not typical for ADLD) usually appear early in the ALSP disease course. Affected individuals subsequently develop motor impairment and gait dysfunction. Brain MRI changes include asymmetric bifrontal T<sub>2</sub>-weighted signal changes in the deep subcortical periventricular areas with cerebral atrophy and minimal involvement of the cerebellum and brain stem.</p><p><a href="/books/n/gene/apbd/"><b>Adult polyglucosan body disease</b></a> is an adult-onset <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> leukodystrophy caused by mutation of <i>GBE1</i>. Disease manifestations include neurogenic bladder, gait difficulties, muscle spasticity and weakness, and distal sensory loss mainly in the lower extremities. Cognitive function is mildly <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>. Brain MRI signal changes occur in periventricular, subcortical, and deep white matter with brain and spinal cord atrophy. Nerve biopsy shows the characteristics intraneural polyglucosan bodies.</p><p><a href="/books/n/gene/lbsl/"><b>Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation</b></a>
<b>(LBSL)</b> is an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> leukodystrophy caused by mutation of <i>DARS2</i>. LBSL usually presents in childhood or adolescence but may present in adulthood. The disease is characterized by progressive spasticity, cerebellar ataxia, and dorsal column abnormalities. Dysarthria develops over time. Occasional findings include: epilepsy; learning problems; cognitive decline; and reduced consciousness, neurologic deterioration, and fever following minor head trauma. MRI changes include non-homogeneous signal changes in the cerebral white matter, lateral corticospinal tracts, and dorsal columns in the spinal cord and pyramids including the medulla oblongata. Lactate is elevated in cerebral white matter.</p><p><a href="/books/n/gene/cach/"><b>Childhood ataxia with central nervous system hypomyelination/vanishing white matter</b></a> is an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> leukodystrophy caused by mutation of one of the five genes (<i>EIF2B1</i>, <i>EIF2B2</i>, <i>EIF2B3</i>, <i>EIF2B4</i>, <i>EIF2B5</i>), encoding the eukaryotic translation initiation factor 2B (eIF2B). Adult-onset cases have been reported. Clinical presentation includes mild alteration of intellectual ability and behavioral changes as well as progressive neurologic features such as ataxia, spasticity, and brisk deep tendon reflexes. Optic atrophy and amenorrhea have also been reported. MRI changes include diffuse cerebral white matter signal changes isointense with CSF on T<sub>2</sub>-weighted images.</p><p><a href="/books/n/gene/krabbe/"><b>Krabbe disease</b></a> and <a href="/books/n/gene/mld/"><b>arylsulfatase A deficiency</b></a>
<b>(metachromatic leukodystrophy).</b> These <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> lysosomal storage disorders (caused by mutation of <i>GALC</i> and <i>ARSA</i>, respectively) in which onset is typically infantile may also manifest initially in adults with nonspecific clinical features.</p><p>In adult-onset Krabbe disease [<a class="bk_pop" href="#lad-ad.REF.farina.2000.1478">Farina et al 2000</a>, <a class="bk_pop" href="#lad-ad.REF.wang.2007.268">Wang et al 2007</a>, <a class="bk_pop" href="#lad-ad.REF.abdelhalim.2014.127">Abdelhalim et al 2014</a>, <a class="bk_pop" href="#lad-ad.REF.ahmed.2014.770">Ahmed et al 2014</a>, <a class="bk_pop" href="#lad-ad.REF.van_rappard.2015.261">van Rappard et al 2015</a>]:</p><ul><li class="half_rhythm"><div>MRI signal changes are sometimes confined to the corticospinal tracts, similar to the findings in asymptomatic individuals with ADLD.</div></li><li class="half_rhythm"><div>Characteristic MRI findings are discrete T<sub>2</sub>-weighted hyperintensities along the corticospinal tracts, in contrast to the more widespread changes in symptomatic individuals with ADLD.</div></li><li class="half_rhythm"><div>When MRI findings are more extensive the T<sub>2</sub>-weighted hyperintensities tend to have a more posterior distribution than those seen in ADLD.</div></li></ul><p>In adult-onset metachromatic leukodystrophy MRI T<sub>2</sub>-weighted hyperintensities have a predominantly frontal, periventricular distribution.</p><p><a href="/books/n/gene/x-ald/"><b>X-linked adrenoleukodystrophy</b></a><b>,</b> caused by mutation of <i>ABCD1</i>, can have several phenotypes. The adrenomyeloneuropathy (AMN) <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> demonstrates overlapping clinical features with ADLD: gait disturbance, sphincter control abnormalities, and sexual dysfunction can be seen in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males. Approximately 20% of females who are <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>ABCD1</i> develop neurologic manifestations that resemble AMN but have later onset (age &#x02265;35 years) and milder disease than do affected males. Clinical or radiologic brain involvement can be seen in 40%-45% of affected individuals.</p></div><div id="lad-ad.Management"><h2 id="_lad-ad_Management_">Management</h2><div id="lad-ad.Evaluations_Following_Initial_Dia"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> leukodystrophy with autonomic disease (ADLD), the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Evaluation by a neurologist for evidence of autonomic dysfunction (e.g., orthostatic hypotension), abnormal tone, and/or tremor</div></li><li class="half_rhythm"><div>Psychological evaluation and neuropsychological assessment</div></li><li class="half_rhythm"><div>Assessment by rehabilitation specialists including equipment needs</div></li><li class="half_rhythm"><div>Evaluation of swallowing function and communication</div></li><li class="half_rhythm"><div>Gastroenterology evaluation for bowel dysfunction</div></li><li class="half_rhythm"><div>Urologic evaluation for urinary dysfunction, recurrent urinary tract infection, and erectile dysfunction</div></li><li class="half_rhythm"><div>Audiologic assessment</div></li><li class="half_rhythm"><div>Consultation with clinical geneticist and/or genetic counselor</div></li></ul></div><div id="lad-ad.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>Primary treatment is not possible, but management of symptoms can improve the comfort and care of individuals with this disorder [<a class="bk_pop" href="#lad-ad.REF.van_haren.2015.516">Van Haren et al 2015</a>].</p><p><b>Autonomic dysfunction</b></p><ul><li class="half_rhythm"><div>Neurogenic bladder:</div><ul><li class="half_rhythm"><div>Recurrent urinary tract infections should be addressed with attention to bladder regimens for managing neurogenic bladders and in rare case antibiotic prophylaxis.</div></li><li class="half_rhythm"><div>Urinary urgency may require spasmolytics (e.g., solifenacine succinate).</div></li></ul></li><li class="half_rhythm"><div>Constipation can be managed by good hydration and dietary fiber, although sometimes stool softeners (e.g., docusate) or a laxative is needed.</div></li><li class="half_rhythm"><div>Hypotensive events can be minimized by pharmacologic treatment (mineralocorticoids such as fludrocortisone or vasopressors such as hydrochloride), compressive stockings, physical therapy (to help with rising from supine positions), and increased salt in the diet.</div></li><li class="half_rhythm"><div>Feeding difficulties can be managed with speech therapy and appropriate feeding interventions to assure adequate nutrition while preventing aspiration pneumonia.</div></li><li class="half_rhythm"><div>Sexual dysfunction can be alleviated with sildenafil.</div></li><li class="half_rhythm"><div>Anhidrosis is managed by avoiding overheating.</div></li><li class="half_rhythm"><div>Intensive management of infections should include adequate antipyretic treatment, as symptoms may worsen significantly with fever.</div></li></ul><p><b>Spasticity.</b> Medications that can help reduce muscle tone include oral baclofen or diazepam (GABA agonists) and injectable botulinum toxin for focal muscle spasticity. A good physical therapy regimen can be beneficial in improving joint mobility and function.</p><p><b>Ataxia.</b> Although ataxia is difficult to treat, frequent falls can be managed with strategies to minimize falls and increase strength and adaptive equipment such as walkers or wheelchairs.</p><p><b>Cognitive dysfunction</b> can affect social interactions and financial management. A social worker and financial planner can help anticipate issues of guardianship that may accompany progressive decline.</p><p>Family and patient support/advocacy groups can help address psychosocial consequences.</p></div><div id="lad-ad.Prevention_of_Secondary_Complicat"><h3>Prevention of Secondary Complications</h3><p>The following are appropriate:</p><ul><li class="half_rhythm"><div>Physiotherapy and orthopedic follow-up to address bone health including Vitamin D and calcium supplementations and management of spasticity to prevent joint contractures and dislocation</div></li><li class="half_rhythm"><div>Attention to pulmonary care, including the use of measures to address chronic lung disease from recurrent aspiration events</div></li><li class="half_rhythm"><div>Yearly influenza immunizations</div></li></ul></div><div id="lad-ad.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Because disease manifestations may be exacerbated with fever and infection, care should be taken to avoid whenever possible exposure to those with infections.</p></div><div id="lad-ad.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#lad-ad.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="lad-ad.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="https://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="lad-ad.Genetic_Counseling"><h2 id="_lad-ad_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="lad-ad.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Autosomal dominant leukodystrophy with autonomic disease (ADLD) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p></div><div id="lad-ad.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>To date all individuals diagnosed with ADLD have inherited a large <i>LMNB1</i> <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> (or large <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> upstream of <i>LMNB)</i> from an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent (see <a href="#lad-ad.Molecular_Genetics">Molecular Genetics</a>).</div></li><li class="half_rhythm"><div>To date a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> ADLD-related <i>LMNB1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has not been reported in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>; however, it should be noted that not all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have parents available for testing.</div></li><li class="half_rhythm"><div>The family history of some individuals diagnosed with ADLD may appear to be negative because of failure to recognize the disorder in family members, early death of the parent before the onset of symptoms, or late onset of the disorder in the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent. Therefore, an apparently negative family history cannot be confirmed unless appropriate clinical evaluation and/or <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> has been performed on the parents of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The risk to the sibs of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> depends on the genetic status of the proband's parents.</div></li><li class="half_rhythm"><div>If a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has an ADLD-related <i>LMNB1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the risk to the sibs is 50%; clinical severity may vary within families.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each child of an individual with ADLD has a 50% chance of inheriting the ADLD-related <i>LMNB1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p><b>Other family members.</b> The risk to other family members depends on the status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents: if a parent is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, his or her family members may be at risk.</p></div><div id="lad-ad.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p><b>MRI findings suggestive of leukodystrophy may be seen many years before clinical manifestation of disease.</b> This should perhaps be communicated to relatives at risk, as many persons may undergo MRI of the brain and spinal cord for a variety of unrelated reasons.</p><p><b>Molecular genetic testing of at-risk asymptomatic adult relatives</b> of individuals with ADLD is possible once the ADLD-related <i>LMNB1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member. Such testing should be performed in the context of formal <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a>. This testing is not useful in predicting age of onset, severity, type of symptoms, or rate of progression in asymptomatic individuals. Testing of asymptomatic at-risk individuals with nonspecific or equivocal symptoms is predictive testing, not diagnostic testing.</p><p><b>Molecular genetic testing of asymptomatic individuals younger than age 18 years</b> who are at risk for adult-onset disorders for which no treatment exists is not considered appropriate, primarily because it negates the autonomy of the child with no compelling benefit. Further, concern exists regarding the potential unhealthy adverse effects that such information may have on family dynamics, the risk of discrimination and stigmatization in the future, and the anxiety that such information may cause.</p><p>In a family with an established diagnosis of ADLD, it is appropriate to consider testing symptomatic individuals regardless of age.</p><p>For more information, see the National Society of Genetic Counselors <a href="http://www.nsgc.org/p/bl/et/blogaid=860" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">position statement</a> on genetic testing of minors for adult-onset conditions and the American Academy of Pediatrics and American College of Medical Genetics and Genomics <a href="http://pediatrics.aappublications.org/content/131/3/620.full.pdf" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">policy statement</a>: ethical and policy issues in genetic testing and screening of children.</p><p><b>Considerations in families with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</b> When neither parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> condition has the pathogenic variant or clinical evidence of the disorder, the pathogenic variant is likely <i>de novo</i>. However, possible non-medical explanations can be explored; these include <a class="def" href="/books/n/gene/glossary/def-item/alternate-paternity/">alternate paternity</a> or maternity (e.g., with assisted reproduction) and undisclosed adoption.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or at risk.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="lad-ad.Prenatal_Testing_and_Preimplantat"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the ADLD-related <i>LMNB1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for ADLD are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="lad-ad.Resources"><h2 id="_lad-ad_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>European Leukodystrophy Association (ELA)</b></div><div>2, rue Mi-les-Vignes</div><div>B.P. 61024</div><div>Laxou Cedex 54521</div><div>France</div><div><b>Phone:</b> 03833093 34</div><div><b>Fax:</b> 03833000 68</div><div><b>Email:</b> ela@ela-asso.com</div><div><a href="http://www.ela-asso.com" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ela-asso.com</a></div></li><li class="half_rhythm"><div><b>Leukodystrophy Australia</b></div><div>P O Box 2550</div><div>Mount Waverley Victoria 3149</div><div>Australia</div><div><b>Phone:</b> 1800-141-400 (toll free)</div><div><b>Email:</b> info@leuko.org.au</div><div><a href="http://www.leuko.org.au/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.leuko.org.au</a></div></li><li class="half_rhythm"><div><b>United Leukodystrophy Foundation (ULF)</b></div><div>224 North Second Street</div><div>Suite 2</div><div>DeKalb IL 60115</div><div><b>Phone:</b> 800-728-5483 (toll-free); 815-748-3211</div><div><b>Fax:</b> 815-748-0844</div><div><b>Email:</b> office@ulf.org</div><div><a href="http://www.ulf.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ulf.org</a></div></li><li class="half_rhythm"><div><b>Myelin Disorders Bioregistry Project</b></div><div><b>Email:</b> myelindisorders@cnmc.org</div><div><a href="https://www.chop.edu/research/myelin-disorders-biorepository-project" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Myelin Disorders Bioregistry Project</a></div></li></ul></div><div id="lad-ad.Molecular_Genetics"><h2 id="_lad-ad_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="lad-ad.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Autosomal Dominant Leukodystrophy with Autonomic Disease: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK338165/table/lad-ad.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__lad-ad.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_lad-ad.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_lad-ad.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_lad-ad.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_lad-ad.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_lad-ad.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_lad-ad.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_lad-ad.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/4001" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>LMNB1</i></a></td><td headers="hd_b_lad-ad.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=4001" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">5q23<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_lad-ad.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P20700" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Lamin-B1</a></td><td headers="hd_b_lad-ad.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.interfil.org/details.php?id=NM_005573" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Human Intermediate Filament Database LMNB1</a><br /><a href="http://databases.lovd.nl/shared/genes/LMNB1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">LMNB1 database</a></td><td headers="hd_b_lad-ad.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=LMNB1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">LMNB1</a></td><td headers="hd_b_lad-ad.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=LMNB1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">LMNB1</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="lad-ad.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="lad-ad.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Autosomal Dominant Leukodystrophy with Autonomic Disease (<a href="/omim/150340,169500" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK338165/table/lad-ad.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__lad-ad.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/150340" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">150340</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">LAMIN B1; LMNB1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/169500" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">169500</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD</td></tr></tbody></table></div></div><p><b>Gene structure.</b>
<i>LMNB1</i> (<a href="/nuccore/NM_005573.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_005573.3</a>) contains 11 exons and ten introns. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK338165/#lad-ad.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b>
<a class="bk_pop" href="#lad-ad.REF.giorgio.2013.1160">Giorgio et al [2013]</a> evaluated 31 individuals with ADLD from 20 different families ascertained worldwide and determined that:</p><ul><li class="half_rhythm"><div>The duplicated region associated with ADLD ranged between ~128 kb (the smallest) and ~475 kb (the largest). Of note, the 475-kb <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> was in an inverted orientation and accompanied by a ~500-bp <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>;</div></li><li class="half_rhythm"><div>The minimal <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> needed for ADLD development was ~72 kb extending from 9.8 kb upstream of <i>LMNB1</i> to 1.8 kb downstream of <i>LMNB1</i>;</div></li><li class="half_rhythm"><div>Three families had an <i>LMNB1</i> pathogenic triplication;</div></li><li class="half_rhythm"><div>Replication-based mechanisms may be responsible for the disease-causing <i>LMNB1</i> duplications and <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> rearrangements.</div></li></ul><p>In one family with typical manifestations of ADLD (except for later-onset autonomic findings [<a class="bk_pop" href="#lad-ad.REF.bergui.1997.423">Bergui et al 1997</a>]) but without an <i>LMNB1</i> <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> [<a class="bk_pop" href="#lad-ad.REF.brussino.2010.541">Brussino et al 2010</a>], <a class="bk_pop" href="#lad-ad.REF.giorgio.2015.3143">Giorgio et al [2015]</a> identified a 660-kb <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> located 66 kb upstream of <i>LMNB1</i> that also involved three additional genes (<i>GRAMD3, ALDH7A1</i>, and <i>PHAX)</i>. Although <i>GRAMD3, ALDH7A1</i>, and <i>PHAX</i> are known to be involved in some diseases, their role in ADLD pathogenesis is not clear. One possible explanation is that the deletion results in <i>LMNB1</i> overexpression by an enhancer adoption mechanism. Of note, an experimentally induced simultaneous single-copy loss did not affect lamin B1 expression.</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>LMNB</i>1 encodes lamin-B1, a member of the intermediate filament family of structural proteins and an integral component of the nuclear lamina. It not only provides structural integrity to the nucleus but also plays a role in essential cellular processes such as transcription, DNA replication, DNA repair, and epigenetic regulation [<a class="bk_pop" href="#lad-ad.REF.butinisraeli.2012.464">Butin-Israeli et al 2012</a>, <a class="bk_pop" href="#lad-ad.REF.stancheva.2014.209">Stancheva &#x00026; Schirmer 2014</a>]. Lamin-B1 is widely expressed in various cell types and shows high levels of expression in the brain [<a class="bk_pop" href="#lad-ad.REF.jung.2013.290">Jung et al 2013</a>].</p><p>The first <i>LMNB</i>1 <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> encodes the amino terminal head <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> of lamin-B1 and the beginning of the central red domain; the middle five exons encode the central red domain; and the last exons encode the carboxy terminal domain. The transcriptional unit contains 43-45 kbp and encodes 586 amino acids [<a class="bk_pop" href="#lad-ad.REF.lin.1995.230">Lin &#x00026; Worman 1995</a>, <a class="bk_pop" href="#lad-ad.REF.maeno.1995.342">Maeno et al 1995</a>, <a class="bk_pop" href="#lad-ad.REF.wydner.1996.474">Wydner et al 1996</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The pathology in ADLD is thought to be due to increased levels of lamin-B1 and, as such, there is no abnormal gene product, just an overexpression of the wild type protein.</p><p>In individuals with ADLD:</p><ul><li class="half_rhythm"><div>Fibroblasts exhibit nuclear abnormalities, increased nuclear stiffness, and alterations in RNA <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> [<a class="bk_pop" href="#lad-ad.REF.ferrera.2014.3906">Ferrera et al 2014</a>, <a class="bk_pop" href="#lad-ad.REF.bartolettistella.2015.2746">Bartoletti-Stella et al 2015</a>].</div></li><li class="half_rhythm"><div>Over-expression in muscle cells had an effect on actin and sarcomere function [<a class="bk_pop" href="#lad-ad.REF.columbaro.2013.411">Columbaro et al 2013</a>].</div></li></ul><p>Overexpression of lamin-B1 was found to have deleterious effects in model organisms.</p><ul><li class="half_rhythm"><div>In a fruit fly model, over-expression of lamin-B1 resulted in lethality and a degenerative <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> [<a class="bk_pop" href="#lad-ad.REF.padiath.2006.1114">Padiath et al 2006</a>].</div></li><li class="half_rhythm"><div>In an ADLD mouse model, targeted over-expression of lamin-B1 in oligodendrocytes, but not in neurons or astrocytes, resulted in demyelination and an age-dependent motor dysfunction reminiscent of the human disease [<a class="bk_pop" href="#lad-ad.REF.heng.2013.2719">Heng et al 2013</a>].</div></li><li class="half_rhythm"><div>In an independently derived oligodendrocyte-specific lamin-B1 overexpressing mouse model, vacuolar demyelination of the spinal cord linked to an age-dependent reduction in lipid synthesis was responsible for the degenerative <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> [<a class="bk_pop" href="#lad-ad.REF.rolyan.2015.12002">Rolyan et al 2015</a>].</div></li></ul></div><div id="lad-ad.References"><h2 id="_lad-ad_References_">References</h2><div id="lad-ad.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="lad-ad.REF.abdelhalim.2014.127">Abdelhalim AN, Alberico RA, Barczykowski AL, Duffner PK. Patterns of magnetic resonance imaging abnormalities in symptomatic patients with Krabbe disease correspond to phenotype. <span><span class="ref-journal">Pediatr Neurol. </span>2014;<span class="ref-vol">50</span>:127–34.</span> [<a href="/pubmed/24262341" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24262341</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lad-ad.REF.ahmed.2014.770">Ahmed RM, Murphy E, Davagnanam I, Parton M, Schott JM, Mummery CJ, Rohrer JD, Lachmann RH, Houlden H, Fox NC, Chataway J. A practical approach to diagnosing adult onset leukodystrophies. <span><span class="ref-journal">J Neurol Neurosurg Psychiatry. </span>2014;<span class="ref-vol">85</span>:770–81.</span> [<a href="/pubmed/24357685" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24357685</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lad-ad.REF.bartolettistella.2015.2746">Bartoletti-Stella A, Gasparini L, Giacomini C, Corrado P, Terlizzi R, Giorgio E, Magini P, Seri M, Baruzzi A, Parchi P, Brusco A, Cortelli P, Capellari S. Messenger RNA processing is altered in autosomal dominant leukodystrophy. <span><span class="ref-journal">Hum Mol Genet. </span>2015;<span class="ref-vol">24</span>:2746–56.</span> [<a href="/pmc/articles/PMC4406291/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4406291</span></a>] [<a href="/pubmed/25637521" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25637521</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lad-ad.REF.bergui.1997.423">Bergui M, Bradac GB, Leombruni S, Vaula G, Quattrocolo G. MRI and CT in an autosomal-dominant, adult-onset leukodystrophy. <span><span class="ref-journal">Neuroradiology. </span>1997;<span class="ref-vol">39</span>:423–6.</span> [<a href="/pubmed/9225322" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9225322</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lad-ad.REF.brussino.2009.237">Brussino A, Vaula G, Cagnoli C, Mauro A, Pradotto L, Daniele D, Di Gregorio E, Barberis M, Arduino C, Squadrone S, Abete MC, Migone N, Calabrese O, Brusco A. A novel family with Lamin B1 duplication associated with adult-onset leucoencephalopathy. <span><span class="ref-journal">J Neurol Neurosurg Psychiatry. </span>2009;<span class="ref-vol">80</span>:237–40.</span> [<a href="/pubmed/19151023" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19151023</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lad-ad.REF.brussino.2010.541">Brussino A, Vaula G, Cagnoli C, Panza E, Seri M, Di Gregorio E, Scappaticci S, Camanini S, Daniele D, Bradac GB, Pinessi L, Cavalieri S, Grosso E, Migone N, Brusco A. A family with autosomal dominant leukodystrophy linked to 5q23.2-q23.3 without lamin B1 mutations. <span><span class="ref-journal">Eur J Neurol. </span>2010;<span class="ref-vol">17</span>:541–9.</span> [<a href="/pubmed/19961535" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19961535</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lad-ad.REF.butinisraeli.2012.464">Butin-Israeli V, Adam SA, Goldman AE, Goldman RD. Nuclear lamin functions and disease. <span><span class="ref-journal">Trends Genet. </span>2012;<span class="ref-vol">28</span>:464–71.</span> [<a href="/pmc/articles/PMC3633455/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3633455</span></a>] [<a href="/pubmed/22795640" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22795640</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lad-ad.REF.columbaro.2013.411">Columbaro M, Mattioli E, Maraldi NM, Ortolani M, Gasparini L, D'Apice MR, Postorivo D, Nardone AM, Avnet S, Cortelli P, Liguori R, Lattanzi G. Oct-1 recruitment to the nuclear envelope in adult-onset autosomal dominant leukodystrophy. <span><span class="ref-journal">Biochim Biophys Acta. </span>2013;<span class="ref-vol">1832</span>:411–20.</span> [<a href="/pubmed/23261988" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23261988</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lad-ad.REF.devalia.2014.496">Devalia V, Hamilton MS, Molloy AM., British Committee for Standards in Haematology.  Guidelines for the diagnosis and treatment of cobalamin and folate disorders. <span><span class="ref-journal">Br J Haematol. </span>2014;<span class="ref-vol">166</span>:496–513.</span> [<a href="/pubmed/24942828" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24942828</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lad-ad.REF.dos_santos.2012.579">Dos Santos MM, Grond-Ginsbach C, Aksay SS, Chen B, Tchatchou S, Wolf NI, van der Knaap MS, Grau AJ. Adult-onset autosomal dominant leukodystrophy due to LMNB1 gene duplication. <span><span class="ref-journal">J Neurol. </span>2012;<span class="ref-vol">259</span>:579–81.</span> [<a href="/pubmed/21909802" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21909802</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lad-ad.REF.eldridge.1984.948">Eldridge R, Anayiotos CP, Schlesinger S, Cowen D, Bever C, Patronas N, McFarland H. Hereditary adult-onset leukodystrophy simulating chronic progressive multiple sclerosis. <span><span class="ref-journal">N Engl J Med. </span>1984;<span class="ref-vol">311</span>:948–53.</span> [<a href="/pubmed/6472420" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 6472420</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lad-ad.REF.farina.2000.1478">Farina L, Bizzi A, Finocchiaro G, Pareyson D, Sghirlanzoni A, Bertagnolio B, Savoiardo M, Naidu S, Singhal BS, Wenger DA. MR imaging and proton MR spectroscopy in adult Krabbe disease. <span><span class="ref-journal">AJNR Am J Neuroradiol. </span>2000;<span class="ref-vol">21</span>:1478–82.</span> [<a href="/pubmed/11003282" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11003282</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lad-ad.REF.ferrera.2014.3906">Ferrera D, Canale C, Marotta R, Mazzaro N, Gritti M, Mazzanti M, Capellari S, Cortelli P, Gasparini L. Lamin B1 overexpression increases nuclear rigidity in autosomal dominant leukodystrophy fibroblasts. <span><span class="ref-journal">FASEB J. </span>2014;<span class="ref-vol">28</span>:3906–18.</span> [<a href="/pmc/articles/PMC4139899/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4139899</span></a>] [<a href="/pubmed/24858279" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24858279</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lad-ad.REF.finnsson.2015.412">Finnsson J, Sundblom J, Dahl N, Melberg A, Raininko R. LMNB1-related autosomal-dominant leukodystrophy: Clinical and radiological course. <span><span class="ref-journal">Ann Neurol. </span>2015;<span class="ref-vol">78</span>:412–25.</span> [<a href="/pmc/articles/PMC5054845/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5054845</span></a>] [<a href="/pubmed/26053668" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26053668</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lad-ad.REF.giorgio.2015.3143">Giorgio E, Robyr D, Spielmann M, Ferrero E, Di Gregorio E, Imperiale D, Vaula G, Stamoulis G, Santoni F, Atzori C, Gasparini L, Ferrera D, Canale C, Guipponi M, Pennacchio LA, Antonarakis SE, Brussino A, Brusco A. A large genomic deletion leads to enhancer adoption by the lamin B1 gene: a second path to autosomal dominant adult-onset demyelinating leukodystrophy (ADLD). <span><span class="ref-journal">Hum Mol Genet. </span>2015;<span class="ref-vol">24</span>:3143–54.</span> [<a href="/pmc/articles/PMC4424952/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4424952</span></a>] [<a href="/pubmed/25701871" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25701871</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lad-ad.REF.giorgio.2013.1160">Giorgio E, Rolyan H, Kropp L, Chakka AB, Yatsenko S, Di Gregorio E, Lacerenza D, Vaula G, Talarico F, Mandich P, Toro C, Pierre EE, Labauge P, Capellari S, Cortelli P, Vairo FP, Miguel D, Stubbolo D, Marques LC, Gahl W, Boespflug-Tanguy O, Melberg A, Hassin-Baer S, Cohen OS, Pjontek R, Grau A, Klopstock T, Fogel B, Meijer I, Rouleau G, Bouchard JP, Ganapathiraju M, Vanderver A, Dahl N, Hobson G, Brusco A, Brussino A, Padiath QS. Analysis of LMNB1 duplications in autosomal dominant leukodystrophy provides insights into duplication mechanisms and allele-specific expression. <span><span class="ref-journal">Hum Mutat. </span>2013;<span class="ref-vol">34</span>:1160–71.</span> [<a href="/pmc/articles/PMC3714349/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3714349</span></a>] [<a href="/pubmed/23649844" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23649844</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lad-ad.REF.guaraldi.2011.123">Guaraldi P, Donadio V, Capellari S, Contin M, Casadio MC, Montagna P, Liguori R, Cortelli P. Isolated noradrenergic failure in adult-onset autosomal dominant leukodystrophy. <span><span class="ref-journal">Auton Neurosci. </span>2011;<span class="ref-vol">159</span>:123–6.</span> [<a href="/pubmed/20719577" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20719577</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lad-ad.REF.heng.2013.2719">Heng MY, Lin ST, Verret L, Huang Y, Kamiya S, Padiath QS, Tong Y, Palop JJ, Huang EJ, Pt&#x000e1;&#x0010d;ek LJ, Fu YH. Lamin B1 mediates cell-autonomous neuropathology in a leukodystrophy mouse model. <span><span class="ref-journal">J Clin Invest. </span>2013;<span class="ref-vol">123</span>:2719–29.</span> [<a href="/pmc/articles/PMC3668844/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3668844</span></a>] [<a href="/pubmed/23676464" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23676464</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lad-ad.REF.issac.2015.26">Issac TG, Soundarya S, Christopher R, Chandra SR. Vitamin B12 deficiency: an important reversible co-morbidity in neuropsychiatric manifestations. <span><span class="ref-journal">Indian J Psychol Med. </span>2015;<span class="ref-vol">37</span>:26–9.</span> [<a href="/pmc/articles/PMC4341306/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4341306</span></a>] [<a href="/pubmed/25722508" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25722508</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lad-ad.REF.jung.2013.290">Jung HJ, Lee JM, Yang SH, Young SG, Fong LG. Nuclear lamins in the brain - new insights into function and regulation. <span><span class="ref-journal">Mol Neurobiol. </span>2013;<span class="ref-vol">47</span>:290–301.</span> [<a href="/pmc/articles/PMC3538886/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3538886</span></a>] [<a href="/pubmed/23065386" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23065386</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lad-ad.REF.lin.1995.230">Lin F, Worman HJ. Structural organization of the human gene (LMNB1) encoding nuclear lamin B1. <span><span class="ref-journal">Genomics. </span>1995;<span class="ref-vol">27</span>:230–6.</span> [<a href="/pubmed/7557986" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7557986</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lad-ad.REF.maeno.1995.342">Maeno H, Sugimoto K, Nakajima N. Genomic structure of the mouse gene (Lmnb1) encoding nuclear lamin B1. <span><span class="ref-journal">Genomics. </span>1995;<span class="ref-vol">30</span>:342–6.</span> [<a href="/pubmed/8586436" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8586436</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lad-ad.REF.marklund.2006.608">Marklund L, Melin M, Melberg A, Giedraitis V, Dahl N. Adult-onset autosomal dominant leukodystrophy with autonomic symptoms restricted to 1.5 Mbp on chromosome 5q23. <span><span class="ref-journal">Am J Med Genet B Neuropsychiatr Genet. </span>2006;<span class="ref-vol">141B</span>:608–14.</span> [<a href="/pubmed/16823806" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16823806</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lad-ad.REF.meijer.2008.1496">Meijer IA, Simoes-Lopes AA, Laurent S, Katz T, St-Onge J, Verlaan DJ, Dupr&#x000e9; N, Thibault M, Mathurin J, Bouchard JP, Rouleau GA. A novel duplication confirms the involvement of 5q23.2 in autosomal dominant leukodystrophy. <span><span class="ref-journal">Arch Neurol. </span>2008;<span class="ref-vol">65</span>:1496–501.</span> [<a href="/pubmed/19001169" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19001169</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lad-ad.REF.melberg.2006.904">Melberg A, Hallberg L, Kalimo H, Raininko R. MR characteristics and neuropathology in adult-onset autosomal dominant leukodystrophy with autonomic symptoms. <span><span class="ref-journal">AJNR Am J Neuroradiol. </span>2006;<span class="ref-vol">27</span>:904–11.</span> [<a href="/pubmed/16611789" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16611789</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lad-ad.REF.noseworthy.2000.938">Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG. Multiple sclerosis. <span><span class="ref-journal">N Engl J Med. </span>2000;<span class="ref-vol">343</span>:938–52.</span> [<a href="/pubmed/11006371" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11006371</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lad-ad.REF.padiath.2010.337">Padiath QS, Fu YH. Autosomal dominant leukodystrophy caused by lamin B1 duplications a clinical and molecular case study of altered nuclear function and disease. <span><span class="ref-journal">Methods Cell Biol. </span>2010;<span class="ref-vol">98</span>:337–57.</span> [<a href="/pubmed/20816241" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20816241</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lad-ad.REF.padiath.2006.1114">Padiath QS, Saigoh K, Schiffmann R, Asahara H, Yamada T, Koeppen A, Hogan K, Pt&#x000e1;cek LJ, Fu YH. Lamin B1 duplications cause autosomal dominant leukodystrophy. <span><span class="ref-journal">Nat Genet. </span>2006;<span class="ref-vol">38</span>:1114–23.</span> [<a href="/pubmed/16951681" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16951681</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lad-ad.REF.poser.1983.227">Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. <span><span class="ref-journal">Ann Neurol. </span>1983;<span class="ref-vol">13</span>:227–31.</span> [<a href="/pubmed/6847134" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 6847134</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lad-ad.REF.potic.2013.2124">Potic A, Pavlovic AM, Uziel G, Kozic D, Ostojic J, Rovelli A, Sternic N, Bjelan M, Sarto E, Di Bella D, Taroni F. Adult-onset autosomal dominant leukodystrophy without early autonomic dysfunctions linked to lamin B1 duplication: a phenotypic variant. <span><span class="ref-journal">J Neurol. </span>2013;<span class="ref-vol">260</span>:2124–9.</span> [<a href="/pubmed/23681646" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23681646</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lad-ad.REF.quattrocolo.1997.53">Quattrocolo G, Leombruni S, Vaula G, Bergui M, Riva A, Bradac GB, Bergamini L. Autosomal dominant late-onset leukoencephalopathy. Clinical report of a new Italian family. <span><span class="ref-journal">Eur Neurol. </span>1997;<span class="ref-vol">37</span>:53–61.</span> [<a href="/pubmed/9018034" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9018034</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lad-ad.REF.rabhi.2011.166">Rabhi S, Maaroufi M, Khibri H, Belahsen F, Tizniti S, Berrady R, Bono W. Magnetic resonance imaging findings within the posterior and lateral columns of the spinal cord extended from the medulla oblongata to the thoracic spine in a woman with subacute combined degeneration without hematologic disorders: a case report and review of the literature. <span><span class="ref-journal">J Med Case Rep. </span>2011;<span class="ref-vol">5</span>:166.</span> [<a href="/pmc/articles/PMC3094295/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3094295</span></a>] [<a href="/pubmed/21524288" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21524288</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lad-ad.REF.rolyan.2015.12002">Rolyan H, Tyurina YY, Hernandez M, Amoscato AA, Sparvero LJ, Nmezi BC, Lu Y, Est&#x000e9;cio MR, Lin K, Chen J, He RR, Gong P, Rigatti LH, Dupree J, Bay&#x00131;r H, Kagan VE, Casaccia P, Padiath QS. Defects of lipid synthesis are linked to the age-dependent demyelination caused by lamin B1 overexpression. <span><span class="ref-journal">J Neurosci. </span>2015;<span class="ref-vol">35</span>:12002–17.</span> [<a href="/pmc/articles/PMC4549407/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4549407</span></a>] [<a href="/pubmed/26311780" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26311780</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lad-ad.REF.schuster.2011.65">Schuster J, Sundblom J, Thuresson AC, Hassin-Baer S, Klopstock T, Dichgans M, Cohen OS, Raininko R, Melberg A, Dahl N. Genomic duplications mediate overexpression of lamin B1 in adult-onset autosomal dominant leukodystrophy (ADLD) with autonomic symptoms. <span><span class="ref-journal">Neurogenetics. </span>2011;<span class="ref-vol">12</span>:65–72.</span> [<a href="/pubmed/21225301" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21225301</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lad-ad.REF.schwankhaus.1994.757">Schwankhaus JD, Katz DA, Eldridge R, Schlesinger S, McFarland H. Clinical and pathological features of an autosomal dominant, adult-onset leukodystrophy simulating chronic progressive multiple sclerosis. <span><span class="ref-journal">Arch Neurol. </span>1994;<span class="ref-vol">51</span>:757–66.</span> [<a href="/pubmed/8042923" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8042923</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lad-ad.REF.schwankhaus.1988.1004">Schwankhaus JD, Patronas N, Dorwart R, Eldridge R, Schlesinger S, McFarland H. Computed tomography and magnetic resonance imaging in adult-onset leukodystrophy. <span><span class="ref-journal">Arch Neurol. </span>1988;<span class="ref-vol">45</span>:1004–8.</span> [<a href="/pubmed/3415518" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3415518</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lad-ad.REF.stancheva.2014.209">Stancheva I, Schirmer EC. Nuclear envelope: connecting structural genome organization to regulation of gene expression. <span><span class="ref-journal">Adv Exp Med Biol. </span>2014;<span class="ref-vol">773</span>:209–44.</span> [<a href="/pubmed/24563350" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24563350</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lad-ad.REF.sundblom.2009.328">Sundblom J, Melberg A, Kalimo H, Smits A, Raininko R. MR imaging characteristics and neuropathology of the spinal cord in adult-onset autosomal dominant leukodystrophy with autonomic symptoms. <span><span class="ref-journal">AJNR Am J Neuroradiol. </span>2009;<span class="ref-vol">30</span>:328–35.</span> [<a href="/pubmed/18945794" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18945794</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lad-ad.REF.van_haren.2015.516">Van Haren K, Bonkowsky JL, Bernard G, Murphy JL, Pizzino A, Helman G, Suhr D, Waggoner J, Hobson D, Vanderver A, Patterson MC. GLIA Consortium. Consensus statement on preventive and symptomatic care of leukodystrophy patients. <span><span class="ref-journal">Mol Genet Metab. </span>2015;<span class="ref-vol">114</span>:516–26.</span> [<a href="/pubmed/25577286" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25577286</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lad-ad.REF.van_rappard.2015.261">van Rappard DF, Boelens JJ, Wolf NI. Metachromatic leukodystrophy: Disease spectrum and approaches for treatment. <span><span class="ref-journal">Best Pract Res Clin Endocrinol Metab. </span>2015;<span class="ref-vol">29</span>:261–73.</span> [<a href="/pubmed/25987178" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25987178</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lad-ad.REF.wang.2007.268">Wang C, Melberg A, Weis J, M&#x000e5;nsson JE, Raininko R. The earliest MR imaging and proton MR spectroscopy abnormalities in adult-onset Krabbe disease. <span><span class="ref-journal">Acta Neurol Scand. </span>2007;<span class="ref-vol">116</span>:268–72.</span> [<a href="/pubmed/17824908" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17824908</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lad-ad.REF.wydner.1996.474">Wydner KL, McNeil JA, Lin F, Worman HJ, Lawrence JB. Chromosomal assignment of human nuclear envelope protein genes LMNA, LMNB1, and LBR by fluorescence in situ hybridization. <span><span class="ref-journal">Genomics. </span>1996;<span class="ref-vol">32</span>:474–8.</span> [<a href="/pubmed/8838815" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8838815</span></a>]</div></li></ul></div></div><div id="lad-ad.Chapter_Notes"><h2 id="_lad-ad_Chapter_Notes_">Chapter Notes</h2><div id="lad-ad.Author_Notes"><h3>Author Notes</h3><p><a href="http://www.publichealth.pitt.edu/home/directory/quasar-padiath" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Quasar Padiath</a><br />ADLD &#x02013; University of Pittsburgh Study<br />Email: <a href="mailto:dev@null" data-email="ude.ttip@htaidapq" class="oemail">ude.ttip@htaidapq</a></p><p>The major focus of the Padiath lab is to understand the molecular mechanisms underlying various neurologic diseases with an emphasis on disorders of myelin that are known as leukodystrophies. This work involves the use of clinical-based family studies to identify disease-related genes and the development of animal and cell culture models to elucidate disease mechanisms. As part of his post-doctoral research, Dr Padiath identified lamin B1 duplications as the cause of ADLD and understanding the molecular mechanisms of this disease remains an important area of research in his lab at the University of Pittsburgh.</p></div><div id="lad-ad.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>7 January 2016 (me) Review posted live</div></li><li class="half_rhythm"><div>27 August 2015 (nn) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK338165</span><span class="label">PMID: <a href="/pubmed/26749591" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">26749591</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/higes/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/adnfle/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK338165&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK338165/?report=reader">PubReader</a></li><li><a href="/books/NBK338165/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK338165" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK338165" style="display:none" title="Cite this Page"><div class="bk_tt">Nahhas N, Sabet Rasekh P, Vanderver A, et al. Autosomal Dominant Leukodystrophy with Autonomic Disease. 2016 Jan 7. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK338165/pdf/Bookshelf_NBK338165.pdf">PDF version of this page</a> (614K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#lad-ad.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#lad-ad.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#lad-ad.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#lad-ad.Genetically_Related_Allelic_Disor" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#lad-ad.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#lad-ad.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#lad-ad.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#lad-ad.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#lad-ad.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#lad-ad.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#lad-ad.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=4001[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">LMNB1</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=4188766" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=4188766" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=4188766" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=4188766" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/28769756" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedarticles&amp;logdbfrom=pubmed">An LMNB1 Duplication Caused Adult-Onset Autosomal Dominant Leukodystrophy in Chinese Family: Clinical Manifestations, Neuroradiology and Genetic Diagnosis.</a><span class="source">[Front Mol Neurosci. 2017]</span><div class="brieflinkpop offscreen_noflow">An LMNB1 Duplication Caused Adult-Onset Autosomal Dominant Leukodystrophy in Chinese Family: Clinical Manifestations, Neuroradiology and Genetic Diagnosis.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Dai Y, Ma Y, Li S, Banerjee S, Liang S, Liu Q, Yang Y, Peng B, Cui L, Jin L. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Front Mol Neurosci. 2017; 10:215. Epub 2017 Jul 18.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/21225301" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Genomic duplications mediate overexpression of lamin B1 in adult-onset autosomal dominant leukodystrophy (ADLD) with autonomic symptoms.</a><span class="source">[Neurogenetics. 2011]</span><div class="brieflinkpop offscreen_noflow">Genomic duplications mediate overexpression of lamin B1 in adult-onset autosomal dominant leukodystrophy (ADLD) with autonomic symptoms.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Schuster J, Sundblom J, Thuresson AC, Hassin-Baer S, Klopstock T, Dichgans M, Cohen OS, Raininko R, Melberg A, Dahl N. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Neurogenetics. 2011 Feb; 12(1):65-72. Epub 2011 Jan 12.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/29262292" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Mice overexpressing lamin B1 in oligodendrocytes recapitulate the age-dependent motor signs, but not the early autonomic cardiovascular dysfunction of autosomal-dominant leukodystrophy (ADLD).</a><span class="source">[Exp Neurol. 2018]</span><div class="brieflinkpop offscreen_noflow">Mice overexpressing lamin B1 in oligodendrocytes recapitulate the age-dependent motor signs, but not the early autonomic cardiovascular dysfunction of autosomal-dominant leukodystrophy (ADLD).<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Lo Martire V, Alvente S, Bastianini S, Berteotti C, Bombardi C, Calandra-Buonaura G, Capellari S, Cohen G, Cortelli P, Gasparini L, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Exp Neurol. 2018 Mar; 301(Pt A):1-12. Epub 2017 Dec 17.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/27809427" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">TUBB4A</i>-Related Leukodystrophy</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">TUBB4A</i>-Related Leukodystrophy<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Nahhas N, Conant A, Hamilton E, Curiel J, Simons C, van der Knaap M, Vanderver A. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24501781" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Leukodystrophy Overview</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Leukodystrophy Overview<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Vanderver A, Tonduti D, Schiffmann R, Schmidt J, van der Knaap MS. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=26749591" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=26749591" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e04138939a66ee2bacb9baa">Autosomal Dominant Leukodystrophy with Autonomic Disease - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Autosomal Dominant Leukodystrophy with Autonomic Disease - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:57:29-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal106&amp;ncbi_phid=CE8DC5A9E0406F0100000000054301F0&amp;ncbi_session=CE8DC5A9E0413881_1347SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK338165%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK338165&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK338165/&amp;ncbi_pagename=Autosomal Dominant Leukodystrophy with Autonomic Disease - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8DC5A9E0413881_1347SID /projects/books/PBooks@5.22 portal106 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>